MTOR and myocardial ischemia: Recent studies have shown that mesenchymal stem cell (MSC)-derived exosomes could reduce myocardial ischemia/reperfusion injury and diabetic nephropathy by inducing autophagy via AMPK/mTOR and Akt/mTOR pathways [10, 11].